Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-04-17
Original market date: See footnote 1
2004-05-25
Product name:
LACRISERT
DIN:
02250624
Product Monograph/Veterinary Labelling:
Date:
2021-03-17
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAUSCH & LOMB INC
1400 N Goodman Street
Rochester
New York
United States
14609
Class:
Human
Dosage form(s):
Insert
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
52:13.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Active ingredient group (AIG) number:See footnote5
0150025001
| Active ingredient(s) | Strength |
|---|---|
| HYPROLOSE | 5 MG / INSERT |